TERAZOSIN HYDROCHLORIDE

TERAZOSIN HYDROCHLORIDE was reported 8916 times

TERAZOSIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FORCED EXPIRATORY FLOW DECREASED 9 0.0928
1 EYE PARAESTHESIA 8 0.0510
2 MYASTHENIC SYNDROME 20 0.0258
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 24 0.0226
4 WHITE COAT HYPERTENSION 10 0.0185
5 HERBAL INTERACTION 6 0.0166
6 HYPERPARATHYROIDISM SECONDARY 41 0.0163
7 NEPHROGENIC ANAEMIA 74 0.0160
8 NEOPLASM SKIN 23 0.0148
9 FAECAL VOLUME DECREASED 7 0.0146
10 FORCED VITAL CAPACITY DECREASED 9 0.0138
11 MICTURITION FREQUENCY DECREASED 10 0.0133
12 HYPERTENSIVE URGENCY 6 0.0108
13 LUNG HYPERINFLATION 9 0.0105
14 DIFFUSE ALVEOLAR DAMAGE 11 0.0096
15 NON-CARDIOGENIC PULMONARY OEDEMA 9 0.0085
16 CERVICAL RADICULOPATHY 6 0.0084
17 PROSTATOMEGALY 33 0.0084
18 MALIGNANT HYPERTENSION 7 0.0081
19 BRADYARRHYTHMIA 13 0.0079
20 HYPOCHROMIC ANAEMIA 8 0.0079
21 STOMA COMPLICATION 8 0.0079
22 END STAGE RENAL DISEASE 140 0.0077
23 REBOUND ACID HYPERSECRETION 23 0.0076
24 TRANSPLANT DYSFUNCTION 13 0.0073
25 COVID-19 IMMUNISATION 6 0.0072
26 METABOLIC SURGERY 8 0.0070
27 BLOOD PRESSURE DIASTOLIC ABNORMAL 17 0.0067
28 AORTIC ARTERIOSCLEROSIS 17 0.0066
29 GASTRIC ULCER PERFORATION 8 0.0063
30 BLADDER TRANSITIONAL CELL CARCINOMA 9 0.0063
31 BENIGN PROSTATIC HYPERPLASIA 32 0.0062
32 VULVOVAGINAL MYCOTIC INFECTION 23 0.0058
33 DISTRIBUTIVE SHOCK 13 0.0057
34 HEART VALVE INCOMPETENCE 16 0.0056
35 HYPERTONIC BLADDER 16 0.0055
36 PULSELESS ELECTRICAL ACTIVITY 23 0.0055
37 AORTIC DILATATION 6 0.0054
38 TRANSITIONAL CELL CARCINOMA 7 0.0054
39 POTENTIATING DRUG INTERACTION 18 0.0054
40 HAEMORRHAGIC ANAEMIA 23 0.0052
41 HAEMORRHOIDAL HAEMORRHAGE 24 0.0049
42 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 8 0.0048
43 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 6 0.0047
44 INTERMITTENT CLAUDICATION 7 0.0044
45 CHRONIC KIDNEY DISEASE 333 0.0044
46 URINARY BLADDER HAEMORRHAGE 9 0.0043
47 HYPOVOLAEMIA 25 0.0043
48 NODAL RHYTHM 6 0.0041
49 CERVICAL SPINAL STENOSIS 7 0.0041
50 BLOOD PRESSURE SYSTOLIC ABNORMAL 10 0.0040
51 KIDNEY FIBROSIS 7 0.0040
52 PROSTATIC DISORDER 22 0.0040
53 FOOD INTERACTION 7 0.0040
54 PERIPHERAL VASCULAR DISORDER 20 0.0039
55 CAPILLARY LEAK SYNDROME 8 0.0039
56 ESSENTIAL HYPERTENSION 7 0.0038
57 SNORING 14 0.0037
58 ISCHAEMIC CARDIOMYOPATHY 11 0.0036
59 ORTHOSTATIC HYPOTENSION 62 0.0036
60 COMPUTERISED TOMOGRAM ABNORMAL 8 0.0035
61 BLOOD LOSS ANAEMIA 8 0.0035
62 AORTIC STENOSIS 12 0.0034
63 NIPPLE PAIN 7 0.0034
64 LOWER GASTROINTESTINAL HAEMORRHAGE 25 0.0034
65 PAINFUL RESPIRATION 8 0.0033
66 PROSTATITIS 10 0.0033
67 METASTATIC RENAL CELL CARCINOMA 6 0.0033
68 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 8 0.0032
69 DIVERTICULUM 23 0.0032
70 MECHANICAL VENTILATION 6 0.0032
71 UPPER GASTROINTESTINAL HAEMORRHAGE 53 0.0031
72 TONGUE OEDEMA 12 0.0031
73 BLOOD PRESSURE SYSTOLIC INCREASED 60 0.0031
74 HEPATIC NEOPLASM 10 0.0031
75 HYPOGEUSIA 6 0.0031
76 DEAFNESS NEUROSENSORY 10 0.0030
77 ARTERIOSCLEROSIS CORONARY ARTERY 20 0.0030
78 CARDIOMEGALY 37 0.0030
79 SLEEP APNOEA SYNDROME 56 0.0029
80 RENAL INJURY 86 0.0029
81 MYOPATHY 25 0.0029
82 NOCTURIA 35 0.0029
83 HAEMATOLOGICAL INFECTION 7 0.0029
84 RIGHT VENTRICULAR FAILURE 20 0.0029
85 ATRIOVENTRICULAR BLOCK COMPLETE 19 0.0028
86 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
87 SINUS BRADYCARDIA 27 0.0028
88 JAW FRACTURE 6 0.0028
89 BLOOD TESTOSTERONE DECREASED 19 0.0028
90 BONE LESION 10 0.0028
91 RALES 16 0.0028
92 CAROTID ARTERY OCCLUSION 10 0.0027
93 MEAN CELL VOLUME INCREASED 7 0.0027
94 HYPERKALAEMIA 94 0.0027
95 URINE ANALYSIS ABNORMAL 8 0.0027
96 DIVERTICULUM INTESTINAL HAEMORRHAGIC 6 0.0027
97 REGURGITATION 9 0.0026
98 ANGINA UNSTABLE 17 0.0026
99 PROSTATIC SPECIFIC ANTIGEN INCREASED 36 0.0026
100 PRIAPISM 9 0.0026
101 PROTEIN URINE PRESENT 13 0.0026
102 VIITH NERVE PARALYSIS 9 0.0026
103 BLOOD CREATININE ABNORMAL 9 0.0026
104 RENAL FUNCTION TEST ABNORMAL 12 0.0026
105 CAROTID ARTERY STENOSIS 9 0.0026
106 GASTRIC PERFORATION 7 0.0026
107 BLOOD BLISTER 8 0.0026
108 INGROWING NAIL 6 0.0025
109 ACUTE KIDNEY INJURY 381 0.0025
110 INTERVERTEBRAL DISC DEGENERATION 23 0.0025
111 RENAL FAILURE 330 0.0025
112 CLOSTRIDIUM DIFFICILE COLITIS 26 0.0024
113 MYOSITIS 22 0.0024
114 SPINAL STENOSIS 10 0.0024
115 FINE MOTOR SKILL DYSFUNCTION 7 0.0024
116 THORACIC VERTEBRAL FRACTURE 7 0.0024
117 HAEMORRHAGE URINARY TRACT 6 0.0024
118 PERFORMANCE STATUS DECREASED 11 0.0024
119 HYPERKERATOSIS 13 0.0024
120 BODY TEMPERATURE DECREASED 23 0.0023
121 AUTOIMMUNE HAEMOLYTIC ANAEMIA 8 0.0023
122 BLOOD PRESSURE INADEQUATELY CONTROLLED 14 0.0023
123 EMERGENCY CARE 7 0.0023
124 EPIGASTRIC DISCOMFORT 9 0.0023
125 DYSURIA 84 0.0023
126 AZOTAEMIA 9 0.0023
127 GOUT 40 0.0022
128 HYPERVOLAEMIA 11 0.0022
129 ORTHOPNOEA 7 0.0022
130 TUBULOINTERSTITIAL NEPHRITIS 41 0.0022
131 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
132 LOOSE TOOTH 7 0.0022
133 RED CELL DISTRIBUTION WIDTH INCREASED 9 0.0022
134 GASTROINTESTINAL HAEMORRHAGE 180 0.0022
135 HAEMORRHOIDS 42 0.0022
136 BACK DISORDER 35 0.0022
137 RENAL TUBULAR NECROSIS 21 0.0021
138 PRESYNCOPE 52 0.0021
139 SPINAL COLUMN STENOSIS 10 0.0021
140 SARCOIDOSIS 10 0.0021
141 ROTATOR CUFF SYNDROME 27 0.0021
142 BLOOD GLUCOSE FLUCTUATION 23 0.0021
143 BLOOD PRESSURE FLUCTUATION 50 0.0021
144 OBESITY 33 0.0021
145 HAEMOTHORAX 6 0.0021
146 IRON DEFICIENCY ANAEMIA 19 0.0021
147 SPLENOMEGALY 24 0.0020
148 NECK INJURY 6 0.0020
149 APLASIA PURE RED CELL 7 0.0020
150 IDIOPATHIC PULMONARY FIBROSIS 8 0.0020
151 CORONARY ARTERY DISEASE 61 0.0020
152 INGUINAL HERNIA 12 0.0020
153 ATELECTASIS 19 0.0020
154 DIABETIC FOOT 6 0.0020
155 MASTICATION DISORDER 6 0.0020
156 DIZZINESS POSTURAL 19 0.0020
157 GLOMERULAR FILTRATION RATE DECREASED 24 0.0020
158 BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0019
159 SPINAL OSTEOARTHRITIS 17 0.0019
160 HYPERBILIRUBINAEMIA 20 0.0019
161 BRONCHIECTASIS 13 0.0019
162 ECONOMIC PROBLEM 29 0.0019
163 BLOOD PRESSURE DIASTOLIC DECREASED 14 0.0019
164 HUMERUS FRACTURE 9 0.0019
165 HAEMATOCRIT DECREASED 37 0.0019
166 PSEUDOMONAS INFECTION 16 0.0019
167 EXTRASYSTOLES 13 0.0019
168 BLOOD UREA INCREASED 31 0.0018
169 ATRIOVENTRICULAR BLOCK FIRST DEGREE 8 0.0018
170 TRANSIENT ISCHAEMIC ATTACK 62 0.0018
171 GASTRIC INFECTION 7 0.0018
172 ANHEDONIA 48 0.0018
173 SQUAMOUS CELL CARCINOMA OF SKIN 11 0.0018
174 LACTIC ACIDOSIS 59 0.0018
175 DIABETIC NEUROPATHY 9 0.0018
176 PHYSICAL DISABILITY 8 0.0018
177 HIGH DENSITY LIPOPROTEIN DECREASED 6 0.0018
178 FULL BLOOD COUNT ABNORMAL 19 0.0018
179 PATHOLOGICAL FRACTURE 9 0.0018
180 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 30 0.0018
181 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
182 PULMONARY MASS 26 0.0017
183 DIFFICULTY IN WALKING 6 0.0017
184 EXERCISE TOLERANCE DECREASED 10 0.0017
185 HYPERVENTILATION 10 0.0017
186 WEIGHT FLUCTUATION 18 0.0017
187 UMBILICAL HERNIA 8 0.0017
188 EMBOLIC STROKE 6 0.0017
189 NECROTISING FASCIITIS 6 0.0017
190 ARTERIOSCLEROSIS 16 0.0017
191 BRADYCARDIA 90 0.0017
192 RENAL FAILURE CHRONIC 13 0.0017
193 PROTEINURIA 32 0.0017
194 HYPOTHERMIA 17 0.0017
195 CORONARY ARTERY OCCLUSION 23 0.0017
196 DRUG LEVEL DECREASED 17 0.0017
197 WALKING AID USER 11 0.0017
198 KIDNEY TRANSPLANT REJECTION 8 0.0017
199 RIB FRACTURE 34 0.0017
200 FINGER DEFORMITY 8 0.0016
201 OSTEOPENIA 25 0.0016
202 RENAL CYST 13 0.0016
203 ATRIAL FLUTTER 13 0.0016
204 HEART RATE DECREASED 57 0.0016
205 DIALYSIS 23 0.0016
206 WHEEZING 96 0.0016
207 BASAL CELL CARCINOMA 25 0.0016
208 DIVERTICULUM INTESTINAL 7 0.0016
209 SQUAMOUS CELL CARCINOMA 15 0.0016
210 HYPERLIPIDAEMIA 19 0.0016
211 SOPOR 21 0.0016
212 LUNG INFILTRATION 14 0.0016
213 POLLAKIURIA 66 0.0016
214 BLOOD CREATINE INCREASED 7 0.0016
215 COAGULOPATHY 26 0.0016
216 URINARY RETENTION 52 0.0016
217 HAEMOGLOBIN ABNORMAL 10 0.0016
218 WOUND INFECTION 17 0.0016
219 HAEMOPTYSIS 43 0.0015
220 APNOEA 12 0.0015
221 HYPOTENSION 309 0.0015
222 URINE ABNORMALITY 7 0.0015
223 SKIN CANCER 33 0.0015
224 LUMBAR VERTEBRAL FRACTURE 7 0.0015
225 ARTERIAL OCCLUSIVE DISEASE 12 0.0015
226 BLOOD PRESSURE INCREASED 233 0.0015
227 INCREASED TENDENCY TO BRUISE 14 0.0015
228 BLOOD CHOLESTEROL ABNORMAL 7 0.0015
229 BLOOD ALBUMIN DECREASED 12 0.0015
230 RENAL PAIN 16 0.0015
231 MUSCLE STRAIN 13 0.0015
232 MITRAL VALVE INCOMPETENCE 17 0.0015
233 GASTRITIS EROSIVE 7 0.0015
234 SYNCOPE 150 0.0015
235 MALIGNANT MELANOMA 20 0.0015
236 INTERNAL HAEMORRHAGE 17 0.0015
237 DECREASED ACTIVITY 16 0.0015
238 SPUTUM DISCOLOURED 14 0.0015
239 BLOOD CREATININE INCREASED 96 0.0015
240 ATRIAL FIBRILLATION 143 0.0015
241 HIATUS HERNIA 19 0.0015
242 HICCUPS 12 0.0015
243 PRE-EXISTING CONDITION IMPROVED 9 0.0014
244 CONGESTIVE CARDIOMYOPATHY 6 0.0014
245 LEUKOCYTOSIS 26 0.0014
246 NASAL DRYNESS 9 0.0014
247 RENAL CELL CARCINOMA 7 0.0014
248 ANGIOPATHY 8 0.0014
249 VITREOUS FLOATERS 14 0.0014
250 ATRIOVENTRICULAR BLOCK 11 0.0014
251 CARDIOVASCULAR DISORDER 36 0.0014
252 BLOOD POTASSIUM INCREASED 23 0.0014
253 HAEMORRHAGE INTRACRANIAL 21 0.0014
254 HAEMATURIA 48 0.0014
255 GALLBLADDER DISORDER 25 0.0014
256 CARDIAC VALVE DISEASE 8 0.0014
257 HERNIA 27 0.0014
258 CARDIAC OPERATION 12 0.0014
259 RHABDOMYOLYSIS 58 0.0014
260 ACUTE MYOCARDIAL INFARCTION 41 0.0014
261 CARDIAC MURMUR 12 0.0014
262 BLOOD URIC ACID INCREASED 8 0.0014
263 TRICUSPID VALVE INCOMPETENCE 11 0.0014
264 KLEBSIELLA INFECTION 7 0.0014
265 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
266 SOMNAMBULISM 9 0.0014
267 INITIAL INSOMNIA 14 0.0014
268 PLEURAL EFFUSION 83 0.0014
269 MOUTH HAEMORRHAGE 10 0.0014
270 LYMPHOCYTE COUNT DECREASED 24 0.0014
271 VARICOSE VEIN 7 0.0014
272 DYSPNOEA EXERTIONAL 51 0.0014
273 ISCHAEMIC STROKE 24 0.0013
274 POLYURIA 11 0.0013
275 RENAL FAILURE ACUTE 57 0.0013
276 HEARING IMPAIRED 8 0.0013
277 INTERNATIONAL NORMALISED RATIO INCREASED 38 0.0013
278 HYPOPHAGIA 34 0.0013
279 BLOOD COUNT ABNORMAL 20 0.0013
280 BLOOD URINE PRESENT 25 0.0013
281 AORTIC ANEURYSM 10 0.0013
282 EXOSTOSIS 12 0.0013
283 MICTURITION URGENCY 15 0.0013
284 ECCHYMOSIS 9 0.0013
285 RESPIRATION ABNORMAL 9 0.0013
286 FLUID OVERLOAD 19 0.0013
287 ACUTE RESPIRATORY DISTRESS SYNDROME 23 0.0013
288 ACUTE RESPIRATORY FAILURE 25 0.0013
289 HYPOGLYCAEMIA 63 0.0013
290 ORAL PAIN 29 0.0013
291 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 62 0.0013
292 BACK INJURY 14 0.0013
293 LUNG INFECTION 20 0.0013
294 NEPHROPATHY 12 0.0013
295 RECTAL HAEMORRHAGE 55 0.0013
296 MUSCULOSKELETAL DISCOMFORT 22 0.0013
297 IMMUNODEFICIENCY 19 0.0013
298 PHOTOPSIA 8 0.0013
299 FOOT DEFORMITY 14 0.0013
300 SHOCK 29 0.0013
301 HYPOVOLAEMIC SHOCK 6 0.0013
302 HAEMOGLOBIN DECREASED 128 0.0012
303 MUSCLE DISORDER 10 0.0012
304 CARDIAC FAILURE CONGESTIVE 99 0.0012
305 HOSPICE CARE 12 0.0012
306 SINUS DISORDER 24 0.0012
307 BONE DISORDER 22 0.0012
308 APPETITE DISORDER 8 0.0012
309 HYPERNATRAEMIA 6 0.0012
310 FLUID INTAKE REDUCED 6 0.0012
311 CORONARY ARTERY STENOSIS 6 0.0012
312 METASTASES TO LYMPH NODES 8 0.0012
313 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
314 BLOOD IRON DECREASED 14 0.0012
315 BACTERAEMIA 14 0.0012
316 TOOTH FRACTURE 13 0.0012
317 CATARACT 70 0.0012
318 CARDIAC PACEMAKER INSERTION 7 0.0012
319 INCORRECT DRUG ADMINISTRATION DURATION 33 0.0012
320 MUSCLE TIGHTNESS 19 0.0012
321 MACULAR DEGENERATION 14 0.0012
322 OBSTRUCTIVE AIRWAYS DISORDER 13 0.0012
323 RENAL IMPAIRMENT 98 0.0012
324 POOR VENOUS ACCESS 12 0.0012
325 BLOOD MAGNESIUM DECREASED 10 0.0012
326 OEDEMA PERIPHERAL 141 0.0012
327 VENTRICULAR EXTRASYSTOLES 12 0.0012
328 CHEST DISCOMFORT 118 0.0012
329 TENDERNESS 12 0.0012
330 REBOUND EFFECT 13 0.0011
331 EPISTAXIS 86 0.0011
332 UPPER RESPIRATORY TRACT INFECTION 53 0.0011
333 COORDINATION ABNORMAL 16 0.0011
334 CONSTIPATION 250 0.0011
335 MASS 16 0.0011
336 EOSINOPHILIA 20 0.0011
337 TOOTH INFECTION 15 0.0011
338 PULMONARY CONGESTION 15 0.0011
339 HEAD INJURY 36 0.0011
340 CELLULITIS 57 0.0011
341 PURPURA 10 0.0011
342 SCOLIOSIS 7 0.0011
343 ASTHENIA 424 0.0011
344 HYPERGLYCAEMIA 41 0.0011
345 AGEUSIA 28 0.0011
346 DRUG INTERACTION 178 0.0011
347 SUBDURAL HAEMATOMA 16 0.0011
348 BLOOD SODIUM DECREASED 21 0.0011
349 GINGIVITIS 6 0.0011
350 BLADDER DISORDER 11 0.0011
351 OSTEOMYELITIS 20 0.0011
352 TACHYPNOEA 15 0.0011
353 FLUID RETENTION 56 0.0011
354 ABNORMAL FAECES 9 0.0011
355 FAECALOMA 6 0.0011
356 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 57 0.0011
357 ERECTILE DYSFUNCTION 28 0.0011
358 MYOCLONUS 13 0.0011
359 PROCTALGIA 7 0.0011
360 RED BLOOD CELL COUNT DECREASED 31 0.0011
361 HEMIPLEGIA 9 0.0011
362 VENTRICULAR FIBRILLATION 12 0.0011
363 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
364 NEUTROPHIL COUNT INCREASED 11 0.0011
365 BURSITIS 13 0.0011
366 KIDNEY INFECTION 21 0.0011
367 POLYP 7 0.0011
368 CYSTITIS 34 0.0011
369 OXYGEN SATURATION DECREASED 60 0.0011
370 HEART RATE IRREGULAR 24 0.0011
371 DYSSTASIA 31 0.0011
372 FLATULENCE 60 0.0011
373 SMALL INTESTINAL OBSTRUCTION 13 0.0011
374 HYPERTENSION 223 0.0011
375 TROPONIN INCREASED 8 0.0011
376 CARDIAC FAILURE ACUTE 7 0.0010
377 TRANSFUSION 11 0.0010
378 URINARY INCONTINENCE 31 0.0010
379 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
380 CORONARY ARTERY BYPASS 6 0.0010
381 FALL 347 0.0010
382 FULL BLOOD COUNT DECREASED 21 0.0010
383 DEHYDRATION 139 0.0010
384 INCONTINENCE 11 0.0010
385 OSTEOARTHRITIS 44 0.0010
386 DYSARTHRIA 39 0.0010
387 CONCUSSION 8 0.0010
388 VASCULITIS 12 0.0010
389 URINE OUTPUT DECREASED 9 0.0010
390 BODY HEIGHT DECREASED 11 0.0010
391 PELVIC FRACTURE 8 0.0010
392 PRODUCTIVE COUGH 49 0.0010
393 HIP FRACTURE 33 0.0010
394 NEPHROLITHIASIS 47 0.0010
395 BLOOD PRESSURE DECREASED 68 0.0010
396 PULMONARY HAEMORRHAGE 8 0.0010
397 HALLUCINATION 77 0.0010
398 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
399 WHITE BLOOD CELL COUNT INCREASED 39 0.0010
400 LARGE INTESTINE POLYP 7 0.0010
401 RENAL DISORDER 47 0.0010
402 BLOOD PRESSURE ABNORMAL 20 0.0010
403 ENDOPHTHALMITIS 6 0.0010
404 GASTRIC ULCER 19 0.0010
405 CARPAL TUNNEL SYNDROME 14 0.0010
406 BLOOD DISORDER 8 0.0010
407 PNEUMONIA 323 0.0010
408 ANAEMIA 190 0.0010
409 BALANCE DISORDER 86 0.0010
410 PERICARDIAL EFFUSION 23 0.0010
411 BLINDNESS UNILATERAL 14 0.0010
412 STENT PLACEMENT 8 0.0010
413 EMPHYSEMA 10 0.0010
414 MYASTHENIA GRAVIS 8 0.0010
415 HYPERTENSIVE CRISIS 11 0.0010
416 RETCHING 21 0.0010
417 GASTROOESOPHAGEAL REFLUX DISEASE 79 0.0010
418 PNEUMONIA BACTERIAL 9 0.0010
419 OEDEMA 53 0.0010
420 NERVE COMPRESSION 9 0.0010
421 CHROMATURIA 22 0.0010
422 TENDON RUPTURE 12 0.0010
423 DIABETES MELLITUS 74 0.0010
424 TEMPERATURE INTOLERANCE 10 0.0010
425 FAECES DISCOLOURED 21 0.0010
426 PHARYNGITIS 12 0.0010
427 METASTASES TO LIVER 17 0.0010
428 COLD SWEAT 17 0.0010
429 GINGIVAL BLEEDING 13 0.0010
430 TYPE 2 DIABETES MELLITUS 32 0.0009
431 BLINDNESS TRANSIENT 7 0.0009
432 HYPOPHOSPHATAEMIA 7 0.0009
433 CEREBRAL INFARCTION 23 0.0009
434 SUNBURN 7 0.0009
435 MENTAL STATUS CHANGES 26 0.0009
436 RESPIRATORY DISORDER 28 0.0009
437 HYPOMAGNESAEMIA 13 0.0009
438 HYPERCHOLESTEROLAEMIA 9 0.0009
439 DIZZINESS 460 0.0009
440 CARDIAC FAILURE 74 0.0009
441 LIMB INJURY 25 0.0009
442 HAEMODYNAMIC INSTABILITY 7 0.0009
443 BRADYPHRENIA 6 0.0009
444 CHOLELITHIASIS 30 0.0009
445 BOWEL MOVEMENT IRREGULARITY 7 0.0009
446 ASPIRATION 10 0.0009
447 LOCALISED INFECTION 22 0.0009
448 GRIP STRENGTH DECREASED 8 0.0009
449 MELAENA 20 0.0009
450 INJECTION SITE NODULE 10 0.0009
451 DISORIENTATION 36 0.0009
452 MYOCARDIAL INFARCTION 158 0.0009
453 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
454 OSTEOPOROSIS 37 0.0009
455 EYE HAEMORRHAGE 12 0.0009
456 PLASMA CELL MYELOMA 35 0.0009
457 HAEMORRHAGIC STROKE 7 0.0009
458 DEMENTIA 25 0.0009
459 CEREBROVASCULAR ACCIDENT 151 0.0009
460 DYSPNOEA 504 0.0009
461 SKIN ULCER 23 0.0009
462 MUSCULAR WEAKNESS 101 0.0009
463 HAEMATOMA 23 0.0009
464 DECREASED APPETITE 206 0.0009
465 HEMIPARESIS 15 0.0009
466 HAIR COLOUR CHANGES 11 0.0009
467 RESPIRATORY TRACT CONGESTION 14 0.0009
468 ABNORMAL LOSS OF WEIGHT 6 0.0009
469 CHEST PAIN 163 0.0009
470 CARDIOMYOPATHY 13 0.0009
471 BLOOD CHOLESTEROL INCREASED 41 0.0009
472 URINARY TRACT INFECTION 150 0.0009
473 PERIPHERAL SWELLING 135 0.0009
474 SKIN LESION 24 0.0009
475 PERIPHERAL COLDNESS 12 0.0009
476 PULMONARY OEDEMA 39 0.0009
477 JOINT EFFUSION 6 0.0009
478 RHINITIS 7 0.0009
479 NASAL CONGESTION 51 0.0009
480 PULMONARY HYPERTENSION 18 0.0009
481 WEIGHT DECREASED 241 0.0009
482 PRODUCT DISTRIBUTION ISSUE 8 0.0009
483 CONTUSION 83 0.0009
484 CARDIAC ARREST 71 0.0009
485 MUSCULOSKELETAL PAIN 45 0.0009
486 DEFORMITY 8 0.0009
487 DIARRHOEA HAEMORRHAGIC 8 0.0009
488 KNEE ARTHROPLASTY 18 0.0009
489 HAEMATOCHEZIA 47 0.0009
490 LOSS OF CONSCIOUSNESS 109 0.0008
491 SUDDEN DEATH 9 0.0008
492 HAIR DISORDER 7 0.0008
493 HIP ARTHROPLASTY 13 0.0008
494 LEUKAEMIA 8 0.0008
495 LABORATORY TEST ABNORMAL 25 0.0008
496 SPINAL COMPRESSION FRACTURE 7 0.0008
497 BREAST PAIN 9 0.0008
498 EMBOLISM 7 0.0008
499 NODULE 11 0.0008
500 DELIRIUM 29 0.0008
501 HAEMODIALYSIS 7 0.0008
502 BLOOD POTASSIUM DECREASED 25 0.0008
503 GLAUCOMA 16 0.0008
504 NEUROPATHY PERIPHERAL 79 0.0008
505 VISION BLURRED 114 0.0008
506 BONE DENSITY DECREASED 26 0.0008
507 MYELODYSPLASTIC SYNDROME 12 0.0008
508 RASH MACULAR 29 0.0008
509 BRAIN FOG 13 0.0008
510 CONFUSIONAL STATE 134 0.0008
511 PULMONARY THROMBOSIS 9 0.0008
512 RESTLESS LEGS SYNDROME 15 0.0008
513 SEPSIS 92 0.0008
514 STOMATITIS 50 0.0008
515 INTERVERTEBRAL DISC PROTRUSION 18 0.0008
516 NECK PAIN 46 0.0008
517 ASTHMA 93 0.0008
518 NEURALGIA 20 0.0008
519 VITAMIN D DEFICIENCY 8 0.0008
520 ORAL DISORDER 6 0.0008
521 SCIATICA 13 0.0008
522 DENTAL CARIES 9 0.0008
523 DYSPEPSIA 80 0.0008
524 TOOTH DISORDER 18 0.0008
525 PLATELET COUNT DECREASED 86 0.0008
526 CYST 10 0.0008
527 ANGINA PECTORIS 23 0.0008
528 LOCAL SWELLING 14 0.0008
529 HYDRONEPHROSIS 6 0.0008
530 SALIVARY HYPERSECRETION 8 0.0008
531 BLOOD CALCIUM INCREASED 7 0.0008
532 MYOCARDIAL ISCHAEMIA 9 0.0008
533 POOR QUALITY SLEEP 17 0.0008
534 APHONIA 11 0.0008
535 CHOLECYSTECTOMY 9 0.0008
536 COUGH 220 0.0008
537 LIPASE INCREASED 6 0.0008
538 LETHARGY 45 0.0008
539 PULMONARY FIBROSIS 15 0.0008
540 MUSCULOSKELETAL CHEST PAIN 12 0.0008
541 BACK PAIN 179 0.0008
542 DEEP VEIN THROMBOSIS 50 0.0008
543 PANCYTOPENIA 43 0.0008
544 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
545 LACRIMATION INCREASED 23 0.0008
546 PAIN IN EXTREMITY 224 0.0008
547 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
548 PNEUMOTHORAX 12 0.0008
549 CONJUNCTIVITIS 14 0.0008
550 JOINT SWELLING 91 0.0008
551 GINGIVAL PAIN 6 0.0008
552 FEBRILE NEUTROPENIA 50 0.0008
553 UPPER LIMB FRACTURE 15 0.0008
554 GLYCOSYLATED HAEMOGLOBIN INCREASED 19 0.0008
555 NIGHT SWEATS 24 0.0007
556 LACERATION 7 0.0007
557 BURNING SENSATION 52 0.0007
558 RESPIRATORY FAILURE 54 0.0007
559 DYSGEUSIA 55 0.0007
560 COLON CANCER 11 0.0007
561 RESTLESSNESS 27 0.0007
562 UNRESPONSIVE TO STIMULI 19 0.0007
563 SKIN LACERATION 8 0.0007
564 DYSPHONIA 43 0.0007
565 PALLOR 20 0.0007
566 HYPERSOMNIA 21 0.0007
567 OESOPHAGITIS 8 0.0007
568 BONE LOSS 11 0.0007
569 METASTASES TO BONE 12 0.0007
570 MUSCLE SPASMS 134 0.0007
571 HYPERHIDROSIS 94 0.0007
572 INJECTION SITE EXTRAVASATION 9 0.0007
573 BLOOD GLUCOSE DECREASED 35 0.0007
574 RHINORRHOEA 47 0.0007
575 PHOTOSENSITIVITY REACTION 12 0.0007
576 GAIT DISTURBANCE 139 0.0007
577 CEREBRAL HAEMORRHAGE 26 0.0007
578 ARTHRITIS 57 0.0007
579 ACUTE CORONARY SYNDROME 6 0.0007
580 TOOTH EXTRACTION 9 0.0007
581 INTENTIONAL PRODUCT USE ISSUE 63 0.0007
582 CHOKING 14 0.0007
583 HOT FLUSH 54 0.0007
584 CARDIAC DISORDER 67 0.0007
585 DRY MOUTH 58 0.0007
586 THERAPEUTIC RESPONSE UNEXPECTED 32 0.0007
587 DIARRHOEA 460 0.0007
588 HALLUCINATION, VISUAL 15 0.0007
589 TENDONITIS 11 0.0007
590 HYPOXIA 25 0.0007
591 SEASONAL ALLERGY 10 0.0007
592 IMPAIRED DRIVING ABILITY 8 0.0007
593 FATIGUE 547 0.0007
594 BRONCHOSPASM 10 0.0007
595 ANOREXIA 9 0.0007
596 PRODUCT USE COMPLAINT 11 0.0007
597 ABDOMINAL DISCOMFORT 117 0.0007
598 ARRHYTHMIA 33 0.0007
599 DIPLOPIA 18 0.0007
600 ANOSMIA 10 0.0007
601 SKIN DISORDER 23 0.0007
602 BRONCHITIS 51 0.0007
603 SLUGGISHNESS 7 0.0007
604 GASTROENTERITIS 10 0.0007
605 SPINAL PAIN 8 0.0007
606 RASH PRURITIC 37 0.0007
607 SEXUAL DYSFUNCTION 8 0.0007
608 HYPOAESTHESIA 102 0.0007
609 PANCREATITIS 36 0.0007
610 OROPHARYNGEAL PAIN 63 0.0007
611 THROMBOCYTOPENIA 76 0.0007
612 LIMB DISCOMFORT 21 0.0007
613 PRODUCT SUBSTITUTION ISSUE 39 0.0007
614 TOOTH LOSS 14 0.0007
615 TINNITUS 31 0.0007
616 SKIN HAEMORRHAGE 10 0.0007
617 HYPOACUSIS 29 0.0007
618 HAIR TEXTURE ABNORMAL 9 0.0007
619 THROMBOSIS 54 0.0007
620 HAEMATEMESIS 17 0.0007
621 ABDOMINAL DISTENSION 70 0.0007
622 HEPATIC FUNCTION ABNORMAL 25 0.0007
623 MULTIPLE FRACTURES 11 0.0007
624 GASTROINTESTINAL INFECTION 6 0.0007
625 FEAR 18 0.0007
626 ANAL INCONTINENCE 6 0.0007
627 NIGHTMARE 23 0.0007
628 PULMONARY EMBOLISM 63 0.0007
629 ADRENAL INSUFFICIENCY 8 0.0007
630 PRODUCT AVAILABILITY ISSUE 15 0.0007
631 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
632 EYE PAIN 37 0.0007
633 MOVEMENT DISORDER 21 0.0007
634 DRUG DOSE OMISSION 108 0.0007
635 NEEDLE ISSUE 19 0.0007
636 CANDIDA INFECTION 11 0.0007
637 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 46 0.0006
638 OSTEONECROSIS OF JAW 16 0.0006
639 GENERALISED OEDEMA 8 0.0006
640 BIPOLAR DISORDER 7 0.0006
641 DRY EYE 32 0.0006
642 TASTE DISORDER 13 0.0006
643 BLOOD TEST ABNORMAL 9 0.0006
644 FLANK PAIN 6 0.0006
645 IMPAIRED HEALING 21 0.0006
646 COVID-19 112 0.0006
647 PARANOIA 11 0.0006
648 STAPHYLOCOCCAL INFECTION 21 0.0006
649 PAIN IN JAW 18 0.0006
650 FOOT FRACTURE 12 0.0006
651 DYSPHAGIA 60 0.0006
652 MEDICATION ERROR 35 0.0006
653 NASOPHARYNGITIS 116 0.0006
654 APHASIA 19 0.0006
655 PARALYSIS 9 0.0006
656 HERPES ZOSTER 36 0.0006
657 MALNUTRITION 7 0.0006
658 PARAESTHESIA ORAL 9 0.0006
659 BLISTER 35 0.0006
660 BLOOD CALCIUM DECREASED 7 0.0006
661 UNEVALUABLE EVENT 47 0.0006
662 BLOOD GLUCOSE INCREASED 117 0.0006
663 SWELLING 58 0.0006
664 MENTAL IMPAIRMENT 15 0.0006
665 MEMORY IMPAIRMENT 85 0.0006
666 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 44 0.0006
667 INJECTION SITE INDURATION 8 0.0006
668 SKIN FISSURES 12 0.0006
669 ENCEPHALOPATHY 15 0.0006
670 SPEECH DISORDER 32 0.0006
671 EATING DISORDER 13 0.0006
672 JOINT INJURY 13 0.0006
673 GASTRITIS 16 0.0006
674 ORAL CANDIDIASIS 8 0.0006
675 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22 0.0006
676 TREATMENT NONCOMPLIANCE 33 0.0006
677 ELECTROLYTE IMBALANCE 7 0.0006
678 TREMOR 100 0.0006
679 POST PROCEDURAL HAEMORRHAGE 7 0.0006
680 PRURITUS GENERALISED 13 0.0006
681 INFLUENZA 67 0.0006
682 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 14 0.0006
683 WHITE BLOOD CELL COUNT DECREASED 65 0.0006
684 ABDOMINAL PAIN UPPER 123 0.0006
685 HYPOAESTHESIA ORAL 9 0.0006
686 INSOMNIA 159 0.0006
687 QUALITY OF LIFE DECREASED 8 0.0006
688 DEPRESSION 135 0.0006
689 HAEMORRHAGE 62 0.0006
690 FREQUENT BOWEL MOVEMENTS 16 0.0006
691 FEEDING DISORDER 12 0.0006
692 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
693 THINKING ABNORMAL 11 0.0006
694 ATAXIA 7 0.0006
695 DEVICE RELATED INFECTION 9 0.0006
696 EAR DISCOMFORT 6 0.0006
697 WRIST FRACTURE 7 0.0006
698 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
699 LYMPHOMA 9 0.0006
700 ANKLE FRACTURE 9 0.0006
701 DRUG EFFECT INCOMPLETE 21 0.0006
702 EYE DISCHARGE 6 0.0006
703 DIVERTICULITIS 16 0.0006
704 MYALGIA 98 0.0006
705 SWOLLEN TONGUE 18 0.0006
706 ARTHROPATHY 32 0.0006
707 UNDERDOSE 42 0.0006
708 SEPTIC SHOCK 25 0.0006
709 VERTIGO 35 0.0006
710 ROAD TRAFFIC ACCIDENT 24 0.0006
711 DEAFNESS 15 0.0006
712 CYTOPENIA 7 0.0006
713 EXPIRED PRODUCT ADMINISTERED 19 0.0006
714 CHILLS 67 0.0006
715 INJECTION SITE DISCOMFORT 6 0.0006
716 INJURY 40 0.0006
717 AMNESIA 37 0.0006
718 ABASIA 14 0.0006
719 SINUSITIS 58 0.0006
720 ANXIETY 161 0.0006
721 LYMPHADENOPATHY 20 0.0006
722 ORAL HERPES 11 0.0006
723 BONE PAIN 33 0.0006
724 THIRST 10 0.0006
725 WEIGHT INCREASED 125 0.0006
726 INTESTINAL OBSTRUCTION 21 0.0006
727 MALAISE 244 0.0006
728 BRAIN OEDEMA 7 0.0006
729 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
730 LUNG DISORDER 27 0.0006
731 HYPONATRAEMIA 31 0.0005
732 ARTHRALGIA 228 0.0005
733 EYE DISORDER 18 0.0005
734 THERAPY CESSATION 28 0.0005
735 GASTROINTESTINAL PAIN 6 0.0005
736 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
737 VISUAL ACUITY REDUCED 18 0.0005
738 RASH GENERALISED 14 0.0005
739 PAIN 331 0.0005
740 HEPATIC STEATOSIS 10 0.0005
741 GENERAL PHYSICAL HEALTH DETERIORATION 62 0.0005
742 MIDDLE INSOMNIA 10 0.0005
743 RASH PAPULAR 12 0.0005
744 BEDRIDDEN 7 0.0005
745 PRODUCT USE ISSUE 100 0.0005
746 PHOTOPHOBIA 10 0.0005
747 PRODUCT QUALITY ISSUE 72 0.0005
748 EMOTIONAL DISTRESS 64 0.0005
749 DERMATITIS 11 0.0005
750 HEART RATE INCREASED 52 0.0005
751 FEELING JITTERY 10 0.0005
752 GASTRIC HAEMORRHAGE 6 0.0005
753 PNEUMONIA ASPIRATION 13 0.0005
754 HYPOKALAEMIA 24 0.0005
755 RASH 226 0.0005
756 BLOOD BILIRUBIN INCREASED 14 0.0005
757 DELUSION 8 0.0005
758 PARAESTHESIA 81 0.0005
759 EJECTION FRACTION DECREASED 8 0.0005
760 EAR PAIN 10 0.0005
761 ABDOMINAL PAIN LOWER 13 0.0005
762 INTENTIONAL PRODUCT MISUSE 45 0.0005
763 ACUTE MYELOID LEUKAEMIA 8 0.0005
764 THERAPEUTIC RESPONSE DECREASED 31 0.0005
765 EYE SWELLING 19 0.0005
766 SLEEP DISORDER 36 0.0005
767 FUNGAL INFECTION 17 0.0005
768 HEAD DISCOMFORT 9 0.0005
769 RESPIRATORY ARREST 14 0.0005
770 DISEASE PROGRESSION 60 0.0005
771 PRODUCT DISPENSING ERROR 11 0.0005
772 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
773 CHOLECYSTITIS 6 0.0005
774 HALLUCINATION, AUDITORY 8 0.0005
775 FEELING COLD 14 0.0005
776 ULCER 8 0.0005
777 MOBILITY DECREASED 36 0.0005
778 SPINAL FRACTURE 10 0.0005
779 NERVOUSNESS 26 0.0005
780 TOOTHACHE 9 0.0005
781 SOMNOLENCE 100 0.0005
782 TACHYCARDIA 44 0.0005
783 PALPITATIONS 58 0.0005
784 GLOSSODYNIA 11 0.0005
785 NEUTROPHIL COUNT DECREASED 20 0.0005
786 SNEEZING 11 0.0005
787 THROAT IRRITATION 22 0.0005
788 PRODUCT DOSE OMISSION 32 0.0005
789 BODY TEMPERATURE INCREASED 10 0.0005
790 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
791 MUSCLE SPASTICITY 6 0.0005
792 PRURITUS 187 0.0005
793 ILLNESS 50 0.0005
794 VENTRICULAR TACHYCARDIA 8 0.0005
795 VISUAL IMPAIRMENT 60 0.0005
796 INFECTION 70 0.0005
797 DRUG LEVEL INCREASED 8 0.0005
798 HEADACHE 301 0.0005
799 GAIT INABILITY 16 0.0005
800 HYPOCALCAEMIA 9 0.0005
801 ANGIOEDEMA 21 0.0005
802 MUSCLE ATROPHY 6 0.0005
803 FEELING ABNORMAL 113 0.0005
804 RESPIRATORY DISTRESS 13 0.0005
805 INCREASED APPETITE 9 0.0005
806 INTRAOCULAR PRESSURE INCREASED 6 0.0005
807 PROCEDURAL PAIN 13 0.0005
808 DRUG PRESCRIBING ERROR 9 0.0005
809 ERUCTATION 9 0.0005
810 ABDOMINAL PAIN 108 0.0005
811 CONDITION AGGRAVATED 141 0.0005
812 PYREXIA 160 0.0005
813 FLUSHING 47 0.0005
814 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
815 DEATH 395 0.0005
816 DRUG DISPENSING ERROR 7 0.0005
817 FEELING HOT 28 0.0005
818 MUSCULOSKELETAL STIFFNESS 40 0.0005
819 DRUG ADMINISTRATION ERROR 14 0.0005
820 DISABILITY 9 0.0005
821 CARDIO-RESPIRATORY ARREST 19 0.0005
822 THYROID DISORDER 7 0.0005
823 GYNAECOMASTIA 14 0.0005
824 ADVERSE REACTION 6 0.0005
825 DRUG ERUPTION 8 0.0005
826 PRESCRIBED UNDERDOSE 9 0.0005
827 COLITIS 17 0.0004
828 JOINT RANGE OF MOTION DECREASED 6 0.0004
829 PRODUCT PHYSICAL ISSUE 9 0.0004
830 DRUG EFFECT DECREASED 24 0.0004
831 SWELLING FACE 29 0.0004
832 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 80 0.0004
833 NAUSEA 351 0.0004
834 OCULAR HYPERAEMIA 21 0.0004
835 APPLICATION SITE PRURITUS 10 0.0004
836 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
837 ABNORMAL DREAMS 12 0.0004
838 EYE IRRITATION 25 0.0004
839 COMPLETED SUICIDE 36 0.0004
840 ORAL DISCOMFORT 6 0.0004
841 HUNGER 6 0.0004
842 SKIN EXFOLIATION 36 0.0004
843 SURGERY 25 0.0004
844 DEVICE OCCLUSION 6 0.0004
845 HEPATIC CIRRHOSIS 8 0.0004
846 VOMITING 200 0.0004
847 MUSCULOSKELETAL DISORDER 8 0.0004
848 OFF LABEL USE 368 0.0004
849 DRUG INEFFECTIVE 553 0.0004
850 DYSKINESIA 17 0.0004
851 IMPAIRED QUALITY OF LIFE 6 0.0004
852 EYE PRURITUS 14 0.0004
853 POST PROCEDURAL COMPLICATION 8 0.0004
854 INCORRECT DOSE ADMINISTERED 95 0.0004
855 LUNG NEOPLASM MALIGNANT 17 0.0004
856 PRESCRIBED OVERDOSE 8 0.0004
857 HYPOKINESIA 6 0.0004
858 PANIC ATTACK 15 0.0004
859 APATHY 6 0.0004
860 CIRCULATORY COLLAPSE 7 0.0004
861 ASCITES 12 0.0004
862 GASTRIC DISORDER 14 0.0004
863 INFUSION RELATED REACTION 27 0.0004
864 HYPOTHYROIDISM 13 0.0004
865 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
866 INJECTION SITE MASS 15 0.0004
867 THERAPY NON-RESPONDER 18 0.0004
868 PANCREATITIS ACUTE 9 0.0004
869 MALIGNANT NEOPLASM PROGRESSION 41 0.0004
870 DISEASE RECURRENCE 19 0.0004
871 PROSTATE CANCER 32 0.0004
872 DEPRESSED MOOD 21 0.0004
873 PRODUCT ADMINISTRATION ERROR 8 0.0004
874 ILL-DEFINED DISORDER 24 0.0004
875 BONE MARROW FAILURE 8 0.0004
876 WOUND 11 0.0004
877 ADVERSE EVENT 36 0.0004
878 NEUTROPENIA 53 0.0004
879 DISTURBANCE IN ATTENTION 21 0.0004
880 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
881 MULTIPLE SCLEROSIS RELAPSE 26 0.0004
882 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
883 ABSCESS 6 0.0004
884 NEOPLASM MALIGNANT 25 0.0004
885 URTICARIA 62 0.0004
886 SKIN DISCOLOURATION 17 0.0004
887 THROAT TIGHTNESS 10 0.0004
888 TOXICITY TO VARIOUS AGENTS 62 0.0004
889 OSTEONECROSIS 12 0.0004
890 INFLUENZA LIKE ILLNESS 30 0.0004
891 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
892 RHEUMATOID ARTHRITIS 41 0.0004
893 VIRAL INFECTION 12 0.0004
894 LIP SWELLING 12 0.0004
895 LEUKOPENIA 18 0.0004
896 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
897 HEPATITIS 9 0.0004
898 IRRITABILITY 21 0.0003
899 MULTI-ORGAN FAILURE 6 0.0003
900 EXTRA DOSE ADMINISTERED 14 0.0003
901 ADVERSE DRUG REACTION 31 0.0003
902 HYPERSENSITIVITY 64 0.0003
903 MUCOSAL INFLAMMATION 9 0.0003
904 BLINDNESS 14 0.0003
905 COGNITIVE DISORDER 16 0.0003
906 AGITATION 25 0.0003
907 HOSPITALISATION 52 0.0003
908 EAR INFECTION 9 0.0003
909 INJECTION SITE HAEMORRHAGE 27 0.0003
910 THERAPY INTERRUPTED 24 0.0003
911 HEPATIC FAILURE 10 0.0003
912 MOOD ALTERED 9 0.0003
913 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
914 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
915 DISCOMFORT 20 0.0003
916 SUICIDAL IDEATION 30 0.0003
917 ANAPHYLACTIC REACTION 18 0.0003
918 BLOOD GLUCOSE ABNORMAL 6 0.0003
919 GASTROINTESTINAL DISORDER 29 0.0003
920 FEMUR FRACTURE 10 0.0003
921 MENTAL DISORDER 14 0.0003
922 BACTERIAL INFECTION 6 0.0003
923 PRODUCT PRESCRIBING ISSUE 7 0.0003
924 AGGRESSION 16 0.0003
925 APPLICATION SITE PAIN 7 0.0003
926 INTENTIONAL DOSE OMISSION 9 0.0003
927 CONVULSION 18 0.0003
928 RASH ERYTHEMATOUS 15 0.0003
929 METABOLIC ACIDOSIS 10 0.0003
930 PANCREATIC CARCINOMA 9 0.0003
931 PHARMACEUTICAL PRODUCT COMPLAINT 8 0.0003
932 RESPIRATORY TRACT INFECTION 8 0.0003
933 PRODUCT DOSE OMISSION ISSUE 90 0.0003
934 APPLICATION SITE ERYTHEMA 8 0.0003
935 MUSCLE TWITCHING 7 0.0003
936 C-REACTIVE PROTEIN INCREASED 11 0.0003
937 DRY SKIN 40 0.0003
938 PSORIATIC ARTHROPATHY 12 0.0003
939 SEIZURE 34 0.0003
940 MULTIPLE SCLEROSIS 14 0.0003
941 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 59 0.0003
942 PSORIASIS 38 0.0003
943 DRUG INTOLERANCE 28 0.0003
944 ALOPECIA 55 0.0003
945 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
946 LIVER FUNCTION TEST ABNORMAL 8 0.0003
947 ACCIDENTAL OVERDOSE 10 0.0003
948 ERYTHEMA 55 0.0003
949 JOINT STIFFNESS 7 0.0003
950 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
951 HEPATIC ENZYME INCREASED 18 0.0003
952 MIGRAINE 25 0.0003
953 JAUNDICE 7 0.0003
954 EMOTIONAL DISORDER 8 0.0003
955 INFLAMMATION 13 0.0003
956 TARDIVE DYSKINESIA 7 0.0002
957 INJECTION SITE PAIN 75 0.0002
958 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
959 WITHDRAWAL SYNDROME 10 0.0002
960 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
961 PRODUCT USE IN UNAPPROVED INDICATION 54 0.0002
962 DRUG ABUSE 18 0.0002
963 ECZEMA 11 0.0002
964 OVERDOSE 45 0.0002
965 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
966 ANGER 7 0.0002
967 INJECTION SITE ERYTHEMA 25 0.0002
968 SKIN IRRITATION 9 0.0002
969 INJECTION SITE SWELLING 15 0.0002
970 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 9 0.0002
971 DEVICE ISSUE 17 0.0002
972 MOOD SWINGS 6 0.0002
973 COLITIS ULCERATIVE 8 0.0002
974 INJECTION SITE REACTION 12 0.0002
975 DEVICE MALFUNCTION 12 0.0002
976 BLADDER CANCER 10 0.0002
977 COMA 8 0.0002
978 CRYING 6 0.0002
979 INJECTION SITE BRUISING 13 0.0002
980 ACNE 12 0.0002
981 LIVER DISORDER 7 0.0002
982 NO ADVERSE EVENT 28 0.0002
983 ABNORMAL BEHAVIOUR 6 0.0002
984 SUICIDE ATTEMPT 9 0.0001
985 INTERSTITIAL LUNG DISEASE 7 0.0001
986 DRUG WITHDRAWAL SYNDROME 12 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
988 PRODUCT STORAGE ERROR 11 0.0001
989 SKIN BURNING SENSATION 8 0.0001
990 TREATMENT FAILURE 9 0.0001
991 INJECTION SITE PRURITUS 7 0.0001
992 INTENTIONAL OVERDOSE 6 0.0001
993 BREAST CANCER 6 0.0001
994 DRUG DEPENDENCE 10 0.0001